[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"company:ANAB":3,"prompts:company:0001370053":22,"buybacks:0001370053:12":49,"months:0001370053:36":85,"side:events:0001370053":88,"filings:0001370053":94},{"status":4,"company":5,"choices":20,"suggestions":21},"found",{"cik":6,"name":7,"ticker":8,"exchange":9,"listings":10,"delisted":15,"coverage":16},"0001370053","AnaptysBio, Inc.","ANAB","NASD",[11],{"ticker":8,"glr_ticker":12,"exchange":9,"type":13,"delisted_on":14},"NASD:ANAB","Common Stock",null,false,{"buybacks":17},{"published":18,"published_at":19},true,"2026-11-17",[],[],{"placement":23,"items":24},"company",[25,30,34,38,44],{"id":26,"title":27,"hint":28,"kind":29,"question":27,"target":14},"asr-3nc2","How does a 3nc2 ASR look for me?","Pricer · discount, size vs. ADV","analyze",{"id":31,"title":32,"hint":33,"kind":29,"question":32,"target":14},"compare-3nc2-6nc4","Compare 3nc2 vs 6nc4","Two pricers side by side",{"id":35,"title":36,"hint":37,"kind":29,"question":36,"target":14},"backtest-2y","Backtest an ASR over 2 years","Backtest · chart",{"id":39,"title":40,"hint":41,"kind":42,"question":14,"target":43},"outstanding","What do I have outstanding?","Public · no email needed","page","buybacks#outstanding",{"id":45,"title":46,"hint":47,"kind":48,"question":14,"target":14},"convert-terms","Terms for a new convert","Coming next","soon",{"company":50,"data_as_of":51,"checked_at":52,"has_active_program":18,"authorized_total":53,"remaining_total":61,"nearest_expiration":64,"programs":67,"recent_quarters":83,"did_asr":15,"asrs":84},{"cik":6,"name":7,"ticker":8,"exchange":9},"2026-09-30","2026-11-17T21:14:07.492108Z",{"value":54,"status":55,"as_of":51,"source":56},100000000,"reported",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},"0001193125-26-458494","10-Q","2026-11-12","https:\u002F\u002Fwww.sec.gov\u002FArchives\u002Fedgar\u002Fdata\u002F1370053\u002F000119312526458494\u002F",{"value":54,"status":62,"as_of":51,"source":63},"estimated",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"value":65,"status":55,"as_of":51,"source":66},"2026-12-31",{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},[68],{"authorized":69,"unit":71,"authorized_as_stated":72,"price_as_of":14,"date_authorized":74,"expiration_date":76,"remaining":78,"remaining_as_stated":80,"description":82},{"value":54,"status":55,"as_of":51,"source":70},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},"usd",{"value":54,"status":55,"as_of":51,"source":73},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"value":14,"status":75,"as_of":14,"source":14},"not_found",{"value":65,"status":55,"as_of":51,"source":77},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"value":54,"status":62,"as_of":51,"source":79},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},{"value":54,"status":62,"as_of":51,"source":81},{"accession":57,"form":58,"as_of":51,"filed_at":59,"url":60},"In March 2026, our board of directors approved a stock repurchase program to repurchase up to $100.0 million of shares of our outstanding common stock, par value $0.001 per share (the “2026 Repurchase Program”).",[],[],{"company":86,"data_as_of":51,"items":87},{"cik":6,"name":7,"ticker":8,"exchange":9},[],{"view":89,"sort":90,"total":91,"generated_at":92,"items":93,"next_cursor":14},"all","newest",0,"2026-11-20T10:02:28.184767Z",[],{"company":95,"items":96,"edgar_url":102},{"cik":6,"name":7,"ticker":8,"exchange":9},[97],{"accession":57,"form":58,"filed_at":98,"period_end":51,"url":60,"used_for":99},"2026-11-12T16:21:33Z",[100,101],"programs","remaining_total","https:\u002F\u002Fwww.sec.gov\u002Fcgi-bin\u002Fbrowse-edgar?action=getcompany&CIK=0001370053"]